Dogwood Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.4K Sell
597
-97
-14% -$5.57K 0.01% 189
2026
Q1
$42.1K Buy
694
+252
+57% +$14.7K 0.02% 161
2025
Q4
$23.8K Buy
442
+6
+1% +$289 0.01% 182
2025
Q3
$19.7K Buy
436
+108
+33% +$5.04K 0.01% 188
2025
Q2
$15.4K Buy
328
+25
+8% +$1.23K 0.01% 208
2025
Q1
$18.5K Buy
303
+64
+27% +$3.73K 0.01% 162
2024
Q4
$13.5K Buy
239
+2
+0.8% +$112 0.01% 177
2024
Q3
$12.3K Buy
237
+3
+1% +$141 0.01% 155
2024
Q2
$9.73K Buy
234
+3
+1% +$134 0.01% 175
2024
Q1
$12.5K Buy
231
+3
+1% +$153 0.01% 176
2023
Q4
$11.7K Buy
+228
New +$12K 0.01% 161

Other funds holding BMY

Dogwood Wealth Management's BMY Position: Q2 2026 in Review

Dogwood Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2026, selling an estimated $5.57K and leaving 597 shares worth $34.4K. The position accounts for 0.01% of the portfolio, ranked #189.

Dogwood Wealth Management first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $42.1K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Dogwood Wealth Management held 597 shares of Bristol-Myers Squibb worth $34.4K as of Q2 2026.
  • Dogwood Wealth Management sold 97 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.57K.
  • Bristol-Myers Squibb made up 0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #189 holding.
  • Dogwood Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Dogwood Wealth Management's Bristol-Myers Squibb position peaked at $42.1K in Q1 2026.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.